Healthcare Marketing Blogs
06|10|26
A New Blueprint for Brand Campaigns In Pharma Marketing
Pharma marketers can no longer rely on in-market demand alone to drive growth. In a crowded, AI-powered landscape, brands must build connection and familiarity earlier to unlock stronger performance later. This POV reveals the five pillars behind campaigns that drive real ROI.
05|21|26
Pharma’s AI Influencer Future Depends on One Question: Why Would Anyone Care?
In a new article published on Med Ad News (Pharma Live), Chief Creative Officer Susan Perlbachs explores what recent consumer backlash to AI influencers reveals about the future of influence in healthcare. The takeaway isn’t that audiences reject AI, but that they reject anything that lacks perspective, purpose, or genuine human value.
05|15|26
2026 Pharma AI Overviews Report
In the past four years, AI has altered how users and technology discover and engage with information and continues to evolve and reshape the digital landscape. To better understand this transformation, our GEO/SEO team analyzed 10,000 pharmaceutical-specific keywords, uncovering a hidden layer of AI background searches and a rapidly changing landscape where nearly 75% of keywords now trigger AI Overviews and sources shift frequently.
05|06|26
EVERSANA Appoints Agency and Commercialization Veteran Mike Guarino to Lead Global Agency EVERSANA INTOUCH
EVERSANA appoints Mike Guarino as CEO of EVERSANA INTOUCH to drive AI-powered, data-driven marketing innovation for life sciences brands.
04|22|26
Reimagining Annual Brand Planning With AI
In a recent article for PM360, Chief Strategy Officer John Kenny explores how AI is reshaping the annual brand planning process from a one-time exercise into a more dynamic, insight-driven model that better reflects today’s complex market realities.
04|08|26
The Fourth Hurdle: In the Search for Truth, Will an Algorithm Find Your Drug?
Launch success once depended on approval, access, and adoption, but today, algorithms have become the new gatekeepers. As the patient journey becomes a data journey, this POV, authored by Barry Vucsko, SVP, Strategic Development, examines what it means for marketers when machines decide what evidence rises to the top.
03|17|26
4th Annual Brand Planning Report: Fueling Brand Plan Success Through AI‑Powered Integration
In our fourth annual report, Chief Strategy Officer at EVERSANA INTOUCH, John Kenny, and Senior Partner of EVERSANA MANAGEMENT CONSULTING, Sean Rapson, explore the state of brand planning with input from pharma marketing executives, uncovering persistent gaps in efficiency, consistency, and the ability to harness data effectively.
03|13|26
FDA Warning & Untitled Letters: What Pharma Marketers Need To Know
The FDA’s recent untitled letters signal heightened scrutiny of promotional practices. Download the POV to learn what pharma marketers need to know, and how to proactively mitigate risk while staying compliant.
03|04|26
Rare Disease in Focus: How Innovation Is Accelerating Access for Patients
The rare disease landscape has long been defined by delay, with families frequently facing 7–10 years before receiving a diagnosis. In recognition of Rare Disease Day, Ann Cave, President, Full-Service Agency, wrote an article for PM360 spotlighting how innovation and human insight are reshaping the rare disease landscape.
03|02|26
Creative That Connects: Earning Trust in Rare Disease Communities
In honor of Rare Disease Day, Patrick Brodfuehrer penned an article in Med Ad News that explores what authentic connection really means for the 300 million people worldwide living with a rare disease.